Navigation Links
Did SARS make China a more global player?
Date:4/27/2010

This release is available in Chinese.

This week in PLoS Medicine we continue our series on Global Health Diplomacy with a case study examining whether the SARS epidemic was a "watershed" for China's engagement in global health diplomacy. The case study, by Lai-Ha Chan from the University of Technology Sydney and colleagues from Peking University, is the third in six articles in the series.

Severe acute respiratory syndrome (SARS) was the first global epidemic of the 21st Century, causing mass panic but also generating a discourse on health insecurity around the world. Dr. Chan and colleagues argue that the SARS epidemic exposed a fundamental shortcoming of China's public health surveillance system and forced China to realize that public health is not merely a domestic issue that can be isolated from foreign policy concerns. The authors caution, however, that China's reframing of health as a global public good has been tempered by its sensitivity to foreign interference to its internal affairs, a standpoint that will no doubt be tested further in a globalizing world where infectious diseases and public health concerns cross borders.

The PLoS Medicine Global Health Diplomacy series began with the publication on 20 April 2010 of an introductory article by Harley Feldbaum and Joshua Michaud, and a case study of Brazil's growing leadership in international relations by Kelley Lee and colleagues. The series continues next week with a case study examining the controversies surrounding equitable access to vaccines for avian influenza A (H5N1) and pandemic influenza A (H1N1). The PLoS Medicine series concludes on 11 May 2010 with commentary from high-level diplomats providing critical insights into the challenges of engaging in global health diplomacy.

The guest editor of the Global Health Diplomacy Series is Kelley Lee.


'/>"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Related medicine news :

1. China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
2. China Sky One Medical, Inc. Featured by Science and Technology Daily
3. CordLife Secures Strategic Presence in China
4. China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009
5. China rapidly catching up in research impact
6. Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China
7. China Nepstar Chain Drugstore Announces Change to the Board
8. China a rising star in regenerative medicine despite world skepticism of stem cell therapies
9. Significant urban-rural disparities in injury mortality seen in China
10. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
11. Major milestone achieved by our joint venture in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi ... patients who do not do their research and undergo cosmetic dermatology treatments from unqualified ... midst of a renaissance and every other month a new treatment or device is ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... 02, 2016 , ... Lori G. Cohen and Sara K. ... at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference , ... of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. 5, 2016 ... treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete ... better safety and tolerability profile of ropeginterferon alfa-2b versus HU ... and the ongoing long-term follow-up trial CONTINUATION-PV to obtain European ... intends to present this data to the FDA as it ...
(Date:12/4/2016)... Attorney General of Louisiana , Charles ... firm of Kahn Swick & Foti, LLC ("KSF"), announces that ... LCI ). On November 3, ... in Generic-Drug Probe to Be Filed by Year-End," which reported ... two years ago, now spans more than a dozen companies," ...
Breaking Medicine Technology: